Copyright
©The Author(s) 2019.
World J Gastrointest Oncol. Feb 15, 2019; 11(2): 117-138
Published online Feb 15, 2019. doi: 10.4251/wjgo.v11.i2.117
Published online Feb 15, 2019. doi: 10.4251/wjgo.v11.i2.117
Figure 5 FcγRIIa and FcγRIIIa polymorphism frequencies in healthy subjects and tumor patients.
Values are expressed as percentages. The statistical data were obtained by using goodness-of-fit statistic. Values of P < 0.05 were considered significant. NS: Not significant; HS: Healthy subject; TP: Tumor patients.
- Citation: Berghella AM, Aureli A, Canossi A, Beato TD, Colanardi A, Pellegrini P. Redox, immune and genetic biomarker system for personalized treatments in colorectal cancer. World J Gastrointest Oncol 2019; 11(2): 117-138
- URL: https://www.wjgnet.com/1948-5204/full/v11/i2/117.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v11.i2.117